DASH vs IONS · P/E 76, rev $13.72B vs rev $226.6M
DoorDash, Inc. Class A Common Stock (DASH) versus Ionis Pharmaceuticals Inc (IONS) — a side-by-side from cached financials, not a winner call.
DoorDash, Inc. Class A Common Stock (DASH) is a internet retail company listed on US.
Ionis Pharmaceuticals Inc (IONS) is a biotechnology company listed on NASDAQ.
Latest reported DASH revenue for 2025-12-31 was $13.72B. Net income was $935.0M. Revenue was up 27.9% from 2024-12-31 to 2025-12-31. DASH currently screens at market cap $69.41B and trailing P/E 75.9.
Latest reported IONS revenue for 2024-12-31 was $226.6M. Net income was -$104.3M. Revenue was down 30.2% from 2023-12-31 to 2024-12-31. IONS currently screens at market cap $12.28B.
DASH currently screens at market cap $69.41B and trailing P/E 75.9. IONS currently screens at market cap $12.28B.
Not investment advice. Open the DASH and IONS stock pages for the full models.
Not investment advice.